IBDEI068 ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8194,1,5,0)
 ;;=5^Erythema Multiforme, Minor
 ;;^UTILITY(U,$J,358.3,8194,2)
 ;;=^336634
 ;;^UTILITY(U,$J,358.3,8195,0)
 ;;=695.12^^62^464^29
 ;;^UTILITY(U,$J,358.3,8195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8195,1,4,0)
 ;;=4^695.12
 ;;^UTILITY(U,$J,358.3,8195,1,5,0)
 ;;=5^Erythema Multiforme, Major
 ;;^UTILITY(U,$J,358.3,8195,2)
 ;;=^336635
 ;;^UTILITY(U,$J,358.3,8196,0)
 ;;=695.19^^62^464^32
 ;;^UTILITY(U,$J,358.3,8196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8196,1,4,0)
 ;;=4^695.19
 ;;^UTILITY(U,$J,358.3,8196,1,5,0)
 ;;=5^Erythema, Other Multiforme
 ;;^UTILITY(U,$J,358.3,8196,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,8197,0)
 ;;=078.12^^62^464^44
 ;;^UTILITY(U,$J,358.3,8197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8197,1,4,0)
 ;;=4^078.12
 ;;^UTILITY(U,$J,358.3,8197,1,5,0)
 ;;=5^Plantar Wart
 ;;^UTILITY(U,$J,358.3,8197,2)
 ;;=^336720
 ;;^UTILITY(U,$J,358.3,8198,0)
 ;;=695.13^^62^464^60
 ;;^UTILITY(U,$J,358.3,8198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8198,1,4,0)
 ;;=4^695.13
 ;;^UTILITY(U,$J,358.3,8198,1,5,0)
 ;;=5^Steven-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,8198,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,8199,0)
 ;;=695.14^^62^464^52
 ;;^UTILITY(U,$J,358.3,8199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8199,1,4,0)
 ;;=4^695.14
 ;;^UTILITY(U,$J,358.3,8199,1,5,0)
 ;;=5^SJS-TEN Syndrome
 ;;^UTILITY(U,$J,358.3,8199,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,8200,0)
 ;;=695.15^^62^464^63
 ;;^UTILITY(U,$J,358.3,8200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8200,1,4,0)
 ;;=4^695.15
 ;;^UTILITY(U,$J,358.3,8200,1,5,0)
 ;;=5^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,8200,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,8201,0)
 ;;=V18.0^^62^465^15
 ;;^UTILITY(U,$J,358.3,8201,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8201,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,8201,1,5,0)
 ;;=5^Family H/O Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,8201,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,8202,0)
 ;;=V16.0^^62^465^8
 ;;^UTILITY(U,$J,358.3,8202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8202,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,8202,1,5,0)
 ;;=5^Family H/O Cancer Of Gi Tract
 ;;^UTILITY(U,$J,358.3,8202,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,8203,0)
 ;;=V16.1^^62^465^9
 ;;^UTILITY(U,$J,358.3,8203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8203,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,8203,1,5,0)
 ;;=5^Family H/O Cancer Of Lung
 ;;^UTILITY(U,$J,358.3,8203,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,8204,0)
 ;;=V19.6^^62^465^2
 ;;^UTILITY(U,$J,358.3,8204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8204,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,8204,1,5,0)
 ;;=5^Family H/O Allergic Disorder
 ;;^UTILITY(U,$J,358.3,8204,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,8205,0)
 ;;=V18.2^^62^465^3
 ;;^UTILITY(U,$J,358.3,8205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8205,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,8205,1,5,0)
 ;;=5^Family H/O Anemia
 ;;^UTILITY(U,$J,358.3,8205,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,8206,0)
 ;;=V17.5^^62^465^5
 ;;^UTILITY(U,$J,358.3,8206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8206,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,8206,1,5,0)
 ;;=5^Family H/O Asthma
 ;;^UTILITY(U,$J,358.3,8206,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,8207,0)
 ;;=V17.7^^62^465^4
 ;;^UTILITY(U,$J,358.3,8207,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8207,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,8207,1,5,0)
 ;;=5^Family H/O Arthritis
 ;;^UTILITY(U,$J,358.3,8207,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,8208,0)
 ;;=V19.0^^62^465^6
 ;;^UTILITY(U,$J,358.3,8208,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8208,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,8208,1,5,0)
 ;;=5^Family H/O Blindness
 ;;^UTILITY(U,$J,358.3,8208,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,8209,0)
 ;;=V16.3^^62^465^7
 ;;^UTILITY(U,$J,358.3,8209,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8209,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,8209,1,5,0)
 ;;=5^Family H/O Cancer Of Breast
 ;;^UTILITY(U,$J,358.3,8209,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,8210,0)
 ;;=V16.41^^62^465^10
 ;;^UTILITY(U,$J,358.3,8210,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8210,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,8210,1,5,0)
 ;;=5^Family H/O Cancer Of Ovary
 ;;^UTILITY(U,$J,358.3,8210,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,8211,0)
 ;;=V16.42^^62^465^11
 ;;^UTILITY(U,$J,358.3,8211,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8211,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,8211,1,5,0)
 ;;=5^Family H/O Cancer Of Prostate
 ;;^UTILITY(U,$J,358.3,8211,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,8212,0)
 ;;=V16.43^^62^465^12
 ;;^UTILITY(U,$J,358.3,8212,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8212,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,8212,1,5,0)
 ;;=5^Family H/O Cancer Of Testis
 ;;^UTILITY(U,$J,358.3,8212,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,8213,0)
 ;;=V19.5^^62^465^13
 ;;^UTILITY(U,$J,358.3,8213,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8213,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,8213,1,5,0)
 ;;=5^Family H/O Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,8213,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,8214,0)
 ;;=V19.2^^62^465^14
 ;;^UTILITY(U,$J,358.3,8214,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8214,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,8214,1,5,0)
 ;;=5^Family H/O Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,8214,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,8215,0)
 ;;=V17.3^^62^465^16
 ;;^UTILITY(U,$J,358.3,8215,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8215,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,8215,1,5,0)
 ;;=5^Family H/O Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,8215,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,8216,0)
 ;;=V16.6^^62^465^17
 ;;^UTILITY(U,$J,358.3,8216,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8216,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,8216,1,5,0)
 ;;=5^Family H/O Leukemia
 ;;^UTILITY(U,$J,358.3,8216,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,8217,0)
 ;;=V18.61^^62^465^19
 ;;^UTILITY(U,$J,358.3,8217,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8217,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,8217,1,5,0)
 ;;=5^Family H/O Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,8217,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,8218,0)
 ;;=V17.0^^62^465^20
 ;;^UTILITY(U,$J,358.3,8218,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8218,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,8218,1,5,0)
 ;;=5^Family H/O Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,8218,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,8219,0)
 ;;=V19.4^^62^465^21
 ;;^UTILITY(U,$J,358.3,8219,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8219,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,8219,1,5,0)
 ;;=5^Family H/O Skin Condition
 ;;^UTILITY(U,$J,358.3,8219,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,8220,0)
 ;;=V17.1^^62^465^22
 ;;^UTILITY(U,$J,358.3,8220,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8220,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,8220,1,5,0)
 ;;=5^Family H/O Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,8220,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,8221,0)
 ;;=V16.8^^62^465^18
 ;;^UTILITY(U,$J,358.3,8221,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8221,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,8221,1,5,0)
 ;;=5^Family H/O Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,8221,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,8222,0)
 ;;=V11.1^^62^465^44
 ;;^UTILITY(U,$J,358.3,8222,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8222,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,8222,1,5,0)
 ;;=5^Personal H/O Affective Disorder
 ;;^UTILITY(U,$J,358.3,8222,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,8223,0)
 ;;=V15.89^^62^465^52
 ;;^UTILITY(U,$J,358.3,8223,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8223,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,8223,1,5,0)
 ;;=5^Personal H/O Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,8223,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,8224,0)
 ;;=V11.3^^62^465^45
 ;;^UTILITY(U,$J,358.3,8224,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8224,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,8224,1,5,0)
 ;;=5^Personal H/O Alcoholism
 ;;^UTILITY(U,$J,358.3,8224,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,8225,0)
 ;;=V15.07^^62^465^46
 ;;^UTILITY(U,$J,358.3,8225,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8225,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,8225,1,5,0)
 ;;=5^Personal H/O Allerlgy To Latex
 ;;^UTILITY(U,$J,358.3,8225,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,8226,0)
 ;;=V13.4^^62^465^47
 ;;^UTILITY(U,$J,358.3,8226,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8226,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,8226,1,5,0)
 ;;=5^Personal H/O Arthritis
 ;;^UTILITY(U,$J,358.3,8226,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,8227,0)
 ;;=V12.72^^62^465^48
 ;;^UTILITY(U,$J,358.3,8227,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8227,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,8227,1,5,0)
 ;;=5^Personal H/O Colon Polyps
 ;;^UTILITY(U,$J,358.3,8227,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,8228,0)
 ;;=V12.59^^62^465^49
 ;;^UTILITY(U,$J,358.3,8228,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8228,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,8228,1,5,0)
 ;;=5^Personal H/O Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,8228,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,8229,0)
 ;;=V45.81^^62^465^50
 ;;^UTILITY(U,$J,358.3,8229,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8229,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,8229,1,5,0)
 ;;=5^Personal H/O Coronary Bypass
 ;;^UTILITY(U,$J,358.3,8229,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,8230,0)
 ;;=V15.84^^62^465^51
 ;;^UTILITY(U,$J,358.3,8230,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8230,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,8230,1,5,0)
 ;;=5^Personal H/O Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,8230,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,8231,0)
 ;;=V15.85^^62^465^57
 ;;^UTILITY(U,$J,358.3,8231,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8231,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,8231,1,5,0)
 ;;=5^Personal H/O Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,8231,2)
 ;;=^303407
